Advertisement

Topics

FDA Lifts Clinical Hold on Advaxis Drug, Shares Jump in Morning Trading

20:00 EDT 12 Jul 2018 | BioSpace

Shares of Advaxis are skyrocketing this morning after the company announced the U.S. Food and Drug Administration lifted the clinical hold on its Investigational New Drug Application for a Phase I/II cancer study.

Original Article: FDA Lifts Clinical Hold on Advaxis Drug, Shares Jump in Morning Trading

NEXT ARTICLE

More From BioPortfolio on "FDA Lifts Clinical Hold on Advaxis Drug, Shares Jump in Morning Trading"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...